Skip to main content
SpringerLink
Log in

Ocular Toxoplasmosis

  • Chapter
  • First Online:
Posterior Uveitis

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

Abstract

Toxoplasmosis is a leading cause of infectious posterior uveitis worldwide. In immunocompetent individuals, systemic infection is usually subclinical. Ocular disease may be self-limited, presenting as retinochoroiditis, either early after primary infection or, more frequently, months or years later, by reactivation of latent retinal infection. Diagnosis of ocular toxoplasmosis is mainly clinical, based on typical presentation of focal necrotizing retinochoroiditis, often associated with adjacent chorioretinal scarring. Imaging modalities may be useful to delineate these posterior segment changes. Treatment is based on a combination of antiparasitic drugs and corticosteroids, the later to minimize possible sequelae of intraocular inflammation. Prognosis varies upon size/location of the lesion, as well as the local inflammatory process.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425):1965–76.

    Article  CAS  PubMed  Google Scholar 

  2. Vasconcelos-Santos DV. Ocular manifestations of systemic disease: toxoplasmosis. Curr Opin Ophthalmol. 2012;23(6):543–50.

    Article  PubMed  Google Scholar 

  3. Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol. 2003;136(6):973–88.

    Article  PubMed  Google Scholar 

  4. Oréfice F, Vasconcelos-Santos DV, Cordeiro CA, Oréfice JL, Costa RA. Toxoplasmosis. In: Foster CS, Vitale AT, editors. Diagnosis and treatment of uveitis. New Delhi: Jaypee-Highlights; 2013. p. 544–68.

    Google Scholar 

  5. Orefice JL, Costa RA, Scott IU, Calucci D, Orefice F, Grupo Mineiro de Pesquisa em Doencas Oculares I. Spectral optical coherence tomography findings in patients with ocular toxoplasmosis and active satellite lesions (MINAS report 1). Acta Ophthalmol. 2013;91(1):e41–7.

    Article  PubMed  Google Scholar 

  6. Dubey JP. The history and life cycle of Toxoplasma gondii. In: Weiss LM, Kim K, editors. Toxoplasma gondii – the model apicomplexan: perspectives and methods, vol. 2007. 1st ed. Amsterdam: Elsevier Academic Press; 2007. p. 1–17.

    Google Scholar 

  7. Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology. 2012;139(11):1375–424.

    Article  CAS  PubMed  Google Scholar 

  8. Bahia-Oliveira LM, Jones JL, Azevedo-Silva J, Alves CC, Orefice F, Addiss DG. Highly endemic, waterborne toxoplasmosis in North Rio de Janeiro state, Brazil. Emerg Infect Dis. 2003;9(1):55–62.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Vasconcelos-Santos DV, Azevedo DOM, Campos WR, Oréfice F, Queiroz-Andrade GM, Carellos EVM. Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology. 2009;116(11):2199–205.e1.

    Article  PubMed  Google Scholar 

  10. Peyron F, Wallon M, Kieffer F, Garweg JG. Toxoplasmosis. In: Wilson CB, Nizet V, Maldonado YA, Remington JS, Klein JO, editors. Remington and Klein’s infectious diseases of the fetus and newborn infant. 8th ed. Philadelphia: Saunders; 2016. p. 949–1042.

    Google Scholar 

  11. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet. 1999;353(9167):1829–33.

    Article  CAS  PubMed  Google Scholar 

  12. Silveira C, Belfort R Jr, Muccioli C, Abreu MT, Martins MC, Victora C, Nussenblatt RB, Holland GN. A follow-up study of Toxoplasma gondii infection in southern Brazil. Am J Ophthalmol. 2001;131(3):351–4.

    Article  CAS  PubMed  Google Scholar 

  13. Arantes TE, Silveira C, Holland GN, Muccioli C, Yu F, Jones JL, Goldhardt R, Lewis KG, Belfort R Jr. Ocular involvement following postnatally acquired Toxoplasma gondii infection in Southern Brazil: a 28-year experience. Am J Ophthalmol. 2015;159(6):1002–1012.e1002.

    Article  PubMed  Google Scholar 

  14. Pavesio CE, Lightman S. Toxoplasma gondii and ocular toxoplasmosis: pathogenesis. Br J Ophthalmol. 1996;80(12):1099–107.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Bhopale GM. Pathogenesis of toxoplasmosis. Comp Immunol Microbiol Infect Dis. 2003;26(4):213–22.

    Article  CAS  PubMed  Google Scholar 

  16. Saeij JP, Boyle JP, Boothroyd JC. Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol. 2005;21(10):476–81.

    Article  PubMed  Google Scholar 

  17. Pena HF, Gennari SM, Dubey JP, Su C. Population structure and mouse-virulence of Toxoplasma gondii in Brazil. Int J Parasitol. 2008;38(5):561–9.

    Article  CAS  PubMed  Google Scholar 

  18. Bottos J, Miller RH, Belfort RN, Macedo AC, Belfort R Jr, Grigg ME. Bilateral retinochoroiditis caused by an atypical strain of Toxoplasma gondii. Br J Ophthalmol. 2009;93(11):1546–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Carneiro AC, Andrade GM, Costa JG, Pinheiro BV, Vasconcelos-Santos DV, Ferreira AM, Su C, Januario JN, Vitor RW. Genetic characterization of Toxoplasma gondii revealed highly diverse genotypes for isolates from newborns with congenital toxoplasmosis in southeastern Brazil. J Clin Microbiol. 2013;51(3):901–7.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Silva LA, Reis-Cunha JL, Bartholomeu DC, Vitor RW. Genetic polymorphisms and phenotypic profiles of sulfadiazine-resistant and sensitive Toxoplasma gondii isolates obtained from newborns with congenital toxoplasmosis in Minas Gerais, Brazil. PLoS One. 2017;12(1):e0170689.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Holland GN. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol. 2004;137(1):1–17.

    PubMed  Google Scholar 

  22. Mets MB, Holfels E, Boyer KM, Swisher CN, Roizen N, Stein L, Stein M, Hopkins J, Withers S, Mack D, Luciano R, Patel D, Remington JS, Meier P, McLeod R. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol. 1997;123(1):1–16.

    Article  CAS  PubMed  Google Scholar 

  23. Demar M, Hommel D, Djossou F, Peneau C, Boukhari R, Louvel D, Bourbigot AM, Nasser V, Ajzenberg D, Darde ML, Carme B. Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana. Clin Microbiol Infect. 2012;18(7):E221–31.

    Article  CAS  PubMed  Google Scholar 

  24. Bowen LN, Smith B, Reich D, Quezado M, Nath A. HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment. Nat Rev Neurol. 2016;12(11):662–74.

    Article  CAS  PubMed  Google Scholar 

  25. Balasundaram MB, Andavar R, Palaniswamy M, Venkatapathy N. Outbreak of acquired ocular toxoplasmosis involving 248 patients. Arch Ophthalmol. 2010;128(1):28–32.

    Article  PubMed  Google Scholar 

  26. Oréfice F, Bahia-Oliveira LM. Toxoplasmose. In: Oréfice F, editor. Uveíte clínica e cirúrgica. Rio de Janeiro: Cultura Médica; 2005. p. 699–804.

    Google Scholar 

  27. Smith JR, Cunningham ET Jr. Atypical presentations of ocular toxoplasmosis. Curr Opin Ophthalmol. 2002;13(6):387–92.

    Article  PubMed  Google Scholar 

  28. Holland GN, Muccioli C, Silveira C, Weisz JM, Belfort R Jr, O’Connor GR. Intraocular inflammatory reactions without focal necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis. Am J Ophthalmol. 1999;128(4):413–20.

    Article  CAS  PubMed  Google Scholar 

  29. Garweg JG, de Groot-Mijnes JD, Montoya JG. Diagnostic approach to ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19(4):255–61.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 2002;185(Suppl 1):S73–82.

    Article  PubMed  Google Scholar 

  31. Montoya JG, Parmley S, Liesenfeld O, Jaffe GJ, Remington JS. Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis. Ophthalmology. 1999;106(8):1554–63.

    Article  CAS  PubMed  Google Scholar 

  32. Vasconcelos-Santos DV, Andrade GM, Caiaffa WT. Zika virus, microcephaly, and ocular findings. JAMA Ophthalmol. 2016;134(8):946.

    Article  PubMed  Google Scholar 

  33. Vasconcelos-Santos DV, Dodds EM, Orefice F. Review for disease of the year: differential diagnosis of ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19(3):171–9.

    Article  PubMed  Google Scholar 

  34. Morais FB, Arantes TE, Muccioli C. Current practices in ocular toxoplasmosis: a survey of Brazilian uveitis specialists. Ocul Immunol Inflamm. 2018;26(2):317–23.

    Article  PubMed  Google Scholar 

  35. Kim SJ, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS, Recchia FM. Interventions for toxoplasma retinochoroiditis: a report by the American Academy of ophthalmology. Ophthalmology. 2013;120(2):371–8. https://doi.org/10.1016/j.ophtha.2012.07.061.

    Article  PubMed  Google Scholar 

  36. Petersen E. Toxoplasmosis. Semin Fetal Neonatal Med. 2007;12(3):214–23.

    Article  PubMed  Google Scholar 

  37. Soheilian M, Ramezani A, Azimzadeh A, Sadoughi MM, Dehghan MH, Shahghadami R, Yaseri M, Peyman GA. Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. Ophthalmology. 2011;118(1):134–41.

    Article  PubMed  Google Scholar 

  38. Heringer GC, Oueghlani E, Dell’Omo R, Curi AL, Orefice F, Pavesio CE. Risk of reactivation of toxoplasmic retinitis following intraocular procedures without the use of prophylactic therapy. Br J Ophthalmol. 2014;98(9):1218–20.

    Article  PubMed  Google Scholar 

  39. Orefice JL, Costa RA, Orefice F, Campos W, da Costa-Lima D Jr, Scott IU. Vitreoretinal morphology in active ocular toxoplasmosis: a prospective study by optical coherence tomography. Br J Ophthalmol. 2007;91(6):773–80.

    Article  PubMed  Google Scholar 

  40. Silveira C, Belfort R Jr, Muccioli C, Holland GN, Victora CG, Horta BL, Yu F, Nussenblatt RB. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 2002;134(1):41–6.

    Article  CAS  PubMed  Google Scholar 

  41. Fernandes Felix JP, Cavalcanti Lira RP, Cosimo AB, Cardeal da Costa RL, Nascimento MA, Leite Arieta CE. Trimethoprim-sulfamethoxazole versus placebo in reducing the risk of toxoplasmic retinochoroiditis recurrences: a three-year follow-up. Am J Ophthalmol. 2016;170:176–82.

    Article  CAS  PubMed  Google Scholar 

  42. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology. 2002;109(5):869–78.

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

The author declares that he does not have any conflict of interest.

No human studies were carried out by the author for this article.

Author information

Authors and Affiliations

  1. Universidade Federal de Minas Gerais, Faculdade de Medicina, Belo Horizonte, Brazil

    Daniel Vitor Vasconcelos-Santos

Authors
  1. Daniel Vitor Vasconcelos-Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Vitor Vasconcelos-Santos .

Editor information

Editors and Affiliations

  1. Ophthalmology, USC Roski Eye Institute Ophthalmology, Los Angeles, CA, USA

    Narsing A. Rao

  2. Department of Ophthalmology and Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA

    Julie Schallhorn

  3. Department of Ophthalmology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA

    Damien C. Rodger

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vasconcelos-Santos, D.V. (2019). Ocular Toxoplasmosis. In: Rao, N., Schallhorn, J., Rodger, D. (eds) Posterior Uveitis. Essentials in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-030-03140-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-03140-4_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-03139-8

  • Online ISBN: 978-3-030-03140-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation